Skip to content

Harmony Biosciences Holdings, Inc. HRMY Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
Alkermes logo
AlkermesALKS
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
XER
Xeris Biopharma Holdings, Inc.XERS
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.99B-14.9%

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s deferred tax assets and other non-current assets?
Harmony Biosciences Holdings, Inc. (HRMY) reported deferred tax assets and other non-current assets of $26.43M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
Harmony Biosciences Holdings, Inc.'s deferred tax assets and other non-current assets increased by 345.1% year-over-year, from $5.94M to $26.43M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s deferred tax assets and other non-current assets has grown at a 160.9% compound annual growth rate (CAGR), from $152K to $18.37M.